Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.
P Ruiz-Garbajosa, R Cantón - Revista Espanola de …, 2017 - search.ebscohost.com
Pseudomonas aeruginosa is one of the major pathogens causing hospital-acquired
infections. It can easily develop antibiotic resistance through chromosomal mutations or by …
infections. It can easily develop antibiotic resistance through chromosomal mutations or by …
[HTML][HTML] Pseudomonas aeruginosa: an antibiotic resilient pathogen with environmental origin
Highlights•P. aeruginosa is opportunistic pathogen with an environmental origin.•P.
aeruginosa presents low susceptibility to currently used antibiotics.•P. aeruginosa displays a …
aeruginosa presents low susceptibility to currently used antibiotics.•P. aeruginosa displays a …
Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types
P Cholley, M Thouverez, D Hocquet… - Journal of clinical …, 2011 - Am Soc Microbiol
This study aimed to determine the genetic diversity of clinical multidrug-resistant
Pseudomonas aeruginosa. We used pulsed-field gel electrophoresis and multilocus …
Pseudomonas aeruginosa. We used pulsed-field gel electrophoresis and multilocus …
Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa
T Miyoshi-Akiyama, T Tada, N Ohmagari… - Genome biology and …, 2017 - academic.oup.com
Pseudomonas aeruginosa (P. aeruginosa) is one of the most common nosocomial
pathogens worldwide. Although the emergence of multidrug-resistant (MDR) P. aeruginosa …
pathogens worldwide. Although the emergence of multidrug-resistant (MDR) P. aeruginosa …
The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility
VN Kos, M Déraspe, RE McLaughlin… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Many clinical isolates of Pseudomonas aeruginosa cause infections that are difficult to
eradicate due to their resistance to a wide variety of antibiotics. Key genetic determinants of …
eradicate due to their resistance to a wide variety of antibiotics. Key genetic determinants of …
Multiresistant serotype O 12 Pseudomonas aeruginosa: evidence for a common strain in Europe
TL Pitt, DM Livermore, D Pitcher… - Epidemiology & …, 1989 - cambridge.org
A survey was made of serotype association and multiple antibiotic resistance in strains of
Pseudomonas aeruginosa in Europe. Of 208 epidemiologically distinct strains from 16 …
Pseudomonas aeruginosa in Europe. Of 208 epidemiologically distinct strains from 16 …
Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum β-Lactamase Enzymes: A Newly Emerging Threat in …
Background Treatment of serious infections due to multidrug-resistant (MDR) Pseudomonas
aeruginosa remains a challenge, despite the introduction of novel therapeutics. In this study …
aeruginosa remains a challenge, despite the introduction of novel therapeutics. In this study …
Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study
Objectives Here we report on a long-term outbreak from 2009 to 2012 with an XDR
Pseudomonas aeruginosa on two wards at a university hospital in southern Germany …
Pseudomonas aeruginosa on two wards at a university hospital in southern Germany …
Pseudomonas aeruginosa: a clinical and genomics update
AC Pelegrin, M Palmieri, C Mirande… - FEMS Microbiology …, 2021 - academic.oup.com
Antimicrobial resistance (AMR) has become a global medical priority that needs urgent
resolution. Pseudomonas aeruginosa is a versatile, adaptable bacterial species with …
resolution. Pseudomonas aeruginosa is a versatile, adaptable bacterial species with …
Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program …
Abstract Background The SENTRY Antimicrobial Surveillance Program was established in
1997 and encompasses over 750 000 bacterial isolates from≥ 400 medical centers …
1997 and encompasses over 750 000 bacterial isolates from≥ 400 medical centers …